Sedation Effect of Dexmedetomidine Versus Remifentanil to Fibreoptic Intubation
Dexmedetomidine Versus Remifentanil Target Controlled Infusion for Sedation During Awake Fibreoptic Nasotracheal Intubation
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
A PHASE4 clinical study on Intubation; Difficult, this trial is completed. The trial is conducted by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University and has accumulated 10 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE4
-
Oct 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jun 2018 — Oct 2018 [monthly]
Completed PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE4
First recorded
Nov 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
For direct contact, visit the study record on ClinicalTrials.gov .